ZA201005248B - 4-pyridinone compounds and their use for cancer - Google Patents

4-pyridinone compounds and their use for cancer

Info

Publication number
ZA201005248B
ZA201005248B ZA2010/05248A ZA201005248A ZA201005248B ZA 201005248 B ZA201005248 B ZA 201005248B ZA 2010/05248 A ZA2010/05248 A ZA 2010/05248A ZA 201005248 A ZA201005248 A ZA 201005248A ZA 201005248 B ZA201005248 B ZA 201005248B
Authority
ZA
South Africa
Prior art keywords
cancer
pyridinone compounds
pyridinone
compounds
Prior art date
Application number
ZA2010/05248A
Other languages
English (en)
Inventor
Robert M Borzilleri
Zhen-Wei Cai
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ZA201005248B publication Critical patent/ZA201005248B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA2010/05248A 2008-01-23 2010-07-22 4-pyridinone compounds and their use for cancer ZA201005248B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2284808P 2008-01-23 2008-01-23
PCT/US2009/031649 WO2009094417A1 (en) 2008-01-23 2009-01-22 4-pyridinone compounds and their use for cancer

Publications (1)

Publication Number Publication Date
ZA201005248B true ZA201005248B (en) 2011-09-28

Family

ID=40637826

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2010/05248A ZA201005248B (en) 2008-01-23 2010-07-22 4-pyridinone compounds and their use for cancer

Country Status (22)

Country Link
US (2) US8124768B2 (pl)
EP (1) EP2235002B1 (pl)
JP (1) JP5314050B2 (pl)
KR (1) KR101596527B1 (pl)
CN (1) CN101977906B (pl)
AU (1) AU2009206440B2 (pl)
BR (1) BRPI0906444B8 (pl)
CA (1) CA2713111C (pl)
CO (1) CO6230986A2 (pl)
CY (1) CY1114140T1 (pl)
DK (1) DK2235002T3 (pl)
EA (1) EA017736B1 (pl)
ES (1) ES2398335T3 (pl)
HK (1) HK1143157A1 (pl)
HR (1) HRP20130040T1 (pl)
IL (1) IL207212A (pl)
NZ (1) NZ586630A (pl)
PL (1) PL2235002T3 (pl)
PT (1) PT2235002E (pl)
SI (1) SI2235002T1 (pl)
WO (1) WO2009094417A1 (pl)
ZA (1) ZA201005248B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2011119478A (ru) 2008-10-14 2012-11-27 Нин Си Соединения и способы применения
AU2010229147B2 (en) 2009-03-21 2012-07-05 Sunshine Lake Pharma Co., Ltd. Amino ester derivatives, salts thereof and methods of use
AU2011248441A1 (en) * 2010-04-29 2012-12-20 Deciphera Pharmaceuticals, Llc Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activites
RU2477723C2 (ru) 2011-06-16 2013-03-20 Общество С Ограниченной Ответственностью "Фьюжн Фарма" Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
DK2810937T3 (en) 2012-01-31 2017-03-13 Daiichi Sankyo Co Ltd PYRIDONE DERIVATIVES
US8975282B2 (en) 2012-07-28 2015-03-10 Sunshine Lake Pharma Co., Ltd. Substituted pyrazolone compounds and methods of use
WO2014022117A1 (en) 2012-07-28 2014-02-06 Calitor Sciences, Llc Substituted pyrazolone compounds and methods of use
US20140057926A1 (en) 2012-08-23 2014-02-27 Boehringer Ingelheim International Gmbh Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
US20140057920A1 (en) * 2012-08-23 2014-02-27 Boehringer Ingelheim International Gmbh Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
US9102624B2 (en) * 2012-08-23 2015-08-11 Boehringer Ingelheim International Gmbh Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
TWI723572B (zh) 2014-07-07 2021-04-01 日商第一三共股份有限公司 具有四氫吡喃基甲基之吡啶酮衍生物及其用途
CN105153026B (zh) * 2015-08-21 2018-02-02 江西科技师范大学 含联芳基酰胺结构的索拉非尼衍生物及其制备方法和应用
UY38536A (es) * 2019-01-03 2020-08-31 Array Biopharma Inc Compuestos de quinolina como inhibidores de quinasas tam y met
WO2024067783A1 (zh) * 2022-09-28 2024-04-04 上海济煜医药科技有限公司 含磷类化合物及其制备方法和医药应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0430885A3 (en) 1989-12-01 1991-11-06 Ciba-Geigy Ag Anthelmintical compounds
DE69622183D1 (de) * 1995-11-07 2002-08-08 Kirin Brewery Chinolinderivate und chinazolinderivate welche die autophosphorylierung des von blutplättchen abstammenden wachstumsfaktorrezeptors inhibiren und sie enthaltende pharmazeutische zusammensetzungen
JP2002518368A (ja) * 1998-06-17 2002-06-25 デュポン ファーマシューティカルズ カンパニー メタロプロテイナーゼ阻害剤としての環式ヒドロキサム酸類
US6355660B1 (en) * 1999-07-20 2002-03-12 Dow Agrosciences Llc Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
AU780698B2 (en) * 1999-07-20 2005-04-14 Dow Agrosciences Llc Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
WO2001021596A1 (en) 1999-09-21 2001-03-29 Astrazeneca Ab Quinazoline derivatives and their use as pharmaceuticals
AU2001243987A1 (en) * 2000-03-22 2001-10-03 Merck Frosst Canada & Co. Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors
FR2812633A1 (fr) * 2000-08-04 2002-02-08 Aventis Cropscience Sa Derives de phenyl(thio)urees et phenyl(thio)carbamates fongicides
SE0102384D0 (sv) * 2001-07-03 2001-07-03 Pharmacia Ab New compounds
WO2003045921A1 (en) * 2001-11-28 2003-06-05 Fujisawa Pharmaceutical Co., Ltd. Heterocyclic amide compounds as apolipoprotein b inhibitors
SE0302487D0 (sv) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
JP4829506B2 (ja) * 2004-02-17 2011-12-07 石原産業株式会社 チオアミド系化合物又はその塩、並びにそれらを含有するサイトカイン産生抑制剤
US7459562B2 (en) * 2004-04-23 2008-12-02 Bristol-Myers Squibb Company Monocyclic heterocycles as kinase inhibitors
WO2005113494A2 (en) * 2004-05-07 2005-12-01 Amgen Inc. Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
US7439246B2 (en) * 2004-06-28 2008-10-21 Bristol-Myers Squibb Company Fused heterocyclic kinase inhibitors
US7432373B2 (en) * 2004-06-28 2008-10-07 Bristol-Meyers Squibb Company Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
US7173031B2 (en) * 2004-06-28 2007-02-06 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
JO2787B1 (en) 2005-04-27 2014-03-15 امجين إنك, Alternative amide derivatives and methods of use
WO2007033196A1 (en) * 2005-09-14 2007-03-22 Bristol-Myers Squibb Company Met kinase inhibitors
WO2007035428A1 (en) * 2005-09-15 2007-03-29 Bristol-Myers Squibb Company Met kinase inhibitors
US7348325B2 (en) * 2005-11-30 2008-03-25 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
KR101608096B1 (ko) 2008-01-23 2016-03-31 브리스톨-마이어스 스큅 컴퍼니 4-피리디논 화합물 및 암을 위한 그의 용도

Also Published As

Publication number Publication date
EP2235002B1 (en) 2012-11-21
BRPI0906444B8 (pt) 2021-05-25
US20110034416A1 (en) 2011-02-10
KR20100103636A (ko) 2010-09-27
IL207212A (en) 2015-01-29
IL207212A0 (en) 2010-12-30
CY1114140T1 (el) 2016-07-27
BRPI0906444B1 (pt) 2021-03-16
BRPI0906444A2 (pt) 2015-07-14
CN101977906A (zh) 2011-02-16
SI2235002T1 (sl) 2013-06-28
EA017736B1 (ru) 2013-02-28
CA2713111A1 (en) 2009-07-30
NZ586630A (en) 2011-12-22
JP2011510087A (ja) 2011-03-31
ES2398335T3 (es) 2013-03-15
HRP20130040T1 (hr) 2013-02-28
US8258118B2 (en) 2012-09-04
WO2009094417A1 (en) 2009-07-30
US20120114643A1 (en) 2012-05-10
KR101596527B1 (ko) 2016-02-22
EA201001196A1 (ru) 2011-02-28
AU2009206440B2 (en) 2013-08-15
PT2235002E (pt) 2013-01-30
JP5314050B2 (ja) 2013-10-16
CN101977906B (zh) 2014-11-05
HK1143157A1 (en) 2010-12-24
AU2009206440A1 (en) 2009-07-30
EP2235002A1 (en) 2010-10-06
CO6230986A2 (es) 2010-12-20
US8124768B2 (en) 2012-02-28
CA2713111C (en) 2015-06-30
BRPI0906444A8 (pt) 2020-02-27
DK2235002T3 (da) 2013-03-11
PL2235002T3 (pl) 2013-04-30

Similar Documents

Publication Publication Date Title
HK1143157A1 (en) 4-pyridinone compounds and their use for cancer 4-
GB0818241D0 (en) Compounds and their use
GB0701426D0 (en) Compounds and their use
IL208081A0 (en) Amido - thiophene compounds and their use
GB0803018D0 (en) Therapeutic compounds and their use
EP2310006A4 (en) TREATMENT OF CANCER
HK1151734A1 (en) Therapeutic for hepatic cancer
ZA201007395B (en) Aryl-quinolyl compounds and their use
SI2344449T1 (sl) Aril-fenil-sulfonamido-cikloalkilne spojine in njihova uporaba
IL212174A0 (en) Substituted aryl compounds and their use
GB0804496D0 (en) Treating cancer
IL206189A0 (en) Compound for use in the treatment of cancer
GB0902173D0 (en) Compounds and their use
IL205308A0 (en) Compounds and methods
GB0812913D0 (en) Therapeutic compounds and their use
GB0801319D0 (en) Compounds and their use
GB201008346D0 (en) Methods and compounds for phototransfer
GB0707556D0 (en) Treatment for cancer
GB0809046D0 (en) Cancer treatment
GB0802128D0 (en) Therapeutic compounds and their use
GB0815134D0 (en) Therapeutic compounds and their use
GB0802195D0 (en) Compounds and their use II
GB0802194D0 (en) Compounds and their use
GB0817897D0 (en) Compounds and their use
GB0813254D0 (en) Compounds and their use